Primary Immunodeficiency Disorders Market
Primary Immunodeficiency Disorders Market - Global Industry Assessment & Forecast
#
Pages:
215
Base Year:
2023
Nov - 2024
Format:
Report Code:
VMR-3149
Segments Covered
By
Disease Antibody Deficiency, Cellular Immunodeficiency, Innate Immune Disorders, Others
-
By
Treatment Immunoglobulin Replacement Therapy, Antibiotic Therapy, Stem Cell/Bone Marrow Transplantation, Gene Therapy, Others
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2032 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD 7.08 Billion |
 Revenue 2032:
|
USD 12.17 Billion |
 Revenue CAGR
(2024 - 2032): |
6.2% |
Fastest Growing Region (2024 -
2032)
|
Asia Pacific |
Largest Region (2023):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Primary Immunodeficiency Disorders Market Segment Analysis
- Primary Immunodeficiency Disorders Disease Outlook (Revenue, USD Million, 2018 - 2030)
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
- Others
- Primary Immunodeficiency Disorders Treatment Outlook (Revenue, USD Million, 2018 - 2030)
- Immunoglobulin Replacement Therapy
- Antibiotic Therapy
- Stem Cell/Bone Marrow Transplantation
- Gene Therapy
- Others
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Primary Immunodeficiency Disorders Market, by Disease
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
- Others
-
North America Primary Immunodeficiency Disorders Market, by Treatment
- Immunoglobulin Replacement Therapy
- Antibiotic Therapy
- Stem Cell/Bone Marrow Transplantation
- Gene Therapy
- Others
- U.S.
- U.S. Primary Immunodeficiency Disorders Market, by Disease
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
- Others
- U.S. Primary Immunodeficiency Disorders Market, by Treatment
- Immunoglobulin Replacement Therapy
- Antibiotic Therapy
- Stem Cell/Bone Marrow Transplantation
- Gene Therapy
- Others
- U.S. Primary Immunodeficiency Disorders Market, by Disease
- Canada
- Canada Primary Immunodeficiency Disorders Market, by Disease
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
- Others
- Canada Primary Immunodeficiency Disorders Market, by Treatment
- Immunoglobulin Replacement Therapy
- Antibiotic Therapy
- Stem Cell/Bone Marrow Transplantation
- Gene Therapy
- Others
- Canada Primary Immunodeficiency Disorders Market, by Disease
-
Mexico
- Mexico Primary Immunodeficiency Disorders Market, by Disease
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
- Others
- Mexico Primary Immunodeficiency Disorders Market, by Treatment
- Immunoglobulin Replacement Therapy
- Antibiotic Therapy
- Stem Cell/Bone Marrow Transplantation
- Gene Therapy
- Others
- Mexico Primary Immunodeficiency Disorders Market, by Disease
-
North America Primary Immunodeficiency Disorders Market, by Disease
- Europe
-
Europe Primary Immunodeficiency Disorders Market, by Disease
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
- Others
-
Europe Primary Immunodeficiency Disorders Market, by Treatment
- Immunoglobulin Replacement Therapy
- Antibiotic Therapy
- Stem Cell/Bone Marrow Transplantation
- Gene Therapy
- Others
- U. K.
- U.K. Primary Immunodeficiency Disorders Market, by Disease
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
- Others
- U.K. Primary Immunodeficiency Disorders Market, by Treatment
- Immunoglobulin Replacement Therapy
- Antibiotic Therapy
- Stem Cell/Bone Marrow Transplantation
- Gene Therapy
- Others
- U.K. Primary Immunodeficiency Disorders Market, by Disease
- France
- France Primary Immunodeficiency Disorders Market, by Disease
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
- Others
- France Primary Immunodeficiency Disorders Market, by Treatment
- Immunoglobulin Replacement Therapy
- Antibiotic Therapy
- Stem Cell/Bone Marrow Transplantation
- Gene Therapy
- Others
- France Primary Immunodeficiency Disorders Market, by Disease
-
Germany
- Germany Primary Immunodeficiency Disorders Market, by Disease
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
- Others
- Germany Primary Immunodeficiency Disorders Market, by Treatment
- Immunoglobulin Replacement Therapy
- Antibiotic Therapy
- Stem Cell/Bone Marrow Transplantation
- Gene Therapy
- Others
- Germany Primary Immunodeficiency Disorders Market, by Disease
-
Italy
- Italy Primary Immunodeficiency Disorders Market, by Disease
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
- Others
- Italy Primary Immunodeficiency Disorders Market, by Treatment
- Immunoglobulin Replacement Therapy
- Antibiotic Therapy
- Stem Cell/Bone Marrow Transplantation
- Gene Therapy
- Others
- Italy Primary Immunodeficiency Disorders Market, by Disease
-
Spain
- Spain Primary Immunodeficiency Disorders Market, by Disease
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
- Others
- Spain Primary Immunodeficiency Disorders Market, by Treatment
- Immunoglobulin Replacement Therapy
- Antibiotic Therapy
- Stem Cell/Bone Marrow Transplantation
- Gene Therapy
- Others
- Spain Primary Immunodeficiency Disorders Market, by Disease
-
Rest of Europe
- Rest of Europe Primary Immunodeficiency Disorders Market, by Disease
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
- Others
- Rest of Europe Primary Immunodeficiency Disorders Market, by Treatment
- Immunoglobulin Replacement Therapy
- Antibiotic Therapy
- Stem Cell/Bone Marrow Transplantation
- Gene Therapy
- Others
- Rest of Europe Primary Immunodeficiency Disorders Market, by Disease
-
Europe Primary Immunodeficiency Disorders Market, by Disease
- Asia Pacific
-
Asia Pacific Primary Immunodeficiency Disorders Market, by Disease
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
- Others
-
Asia Pacific Primary Immunodeficiency Disorders Market, by Treatment
- Immunoglobulin Replacement Therapy
- Antibiotic Therapy
- Stem Cell/Bone Marrow Transplantation
- Gene Therapy
- Others
- China
- China Primary Immunodeficiency Disorders Market, by Disease
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
- Others
- China Primary Immunodeficiency Disorders Market, by Treatment
- Immunoglobulin Replacement Therapy
- Antibiotic Therapy
- Stem Cell/Bone Marrow Transplantation
- Gene Therapy
- Others
- China Primary Immunodeficiency Disorders Market, by Disease
- Japan
- Japan Primary Immunodeficiency Disorders Market, by Disease
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
- Others
- Japan Primary Immunodeficiency Disorders Market, by Treatment
- Immunoglobulin Replacement Therapy
- Antibiotic Therapy
- Stem Cell/Bone Marrow Transplantation
- Gene Therapy
- Others
- Japan Primary Immunodeficiency Disorders Market, by Disease
-
Germany
- Germany Primary Immunodeficiency Disorders Market, by Disease
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
- Others
- Germany Primary Immunodeficiency Disorders Market, by Treatment
- Immunoglobulin Replacement Therapy
- Antibiotic Therapy
- Stem Cell/Bone Marrow Transplantation
- Gene Therapy
- Others
- Germany Primary Immunodeficiency Disorders Market, by Disease
-
India
- India Primary Immunodeficiency Disorders Market, by Disease
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
- Others
- India Primary Immunodeficiency Disorders Market, by Treatment
- Immunoglobulin Replacement Therapy
- Antibiotic Therapy
- Stem Cell/Bone Marrow Transplantation
- Gene Therapy
- Others
- India Primary Immunodeficiency Disorders Market, by Disease
-
South Korea
- South Korea Primary Immunodeficiency Disorders Market, by Disease
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
- Others
- South Korea Primary Immunodeficiency Disorders Market, by Treatment
- Immunoglobulin Replacement Therapy
- Antibiotic Therapy
- Stem Cell/Bone Marrow Transplantation
- Gene Therapy
- Others
- South Korea Primary Immunodeficiency Disorders Market, by Disease
-
South East Asia
- South East Asia Primary Immunodeficiency Disorders Market, by Disease
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
- Others
- South East Asia Primary Immunodeficiency Disorders Market, by Treatment
- Immunoglobulin Replacement Therapy
- Antibiotic Therapy
- Stem Cell/Bone Marrow Transplantation
- Gene Therapy
- Others
- South East Asia Primary Immunodeficiency Disorders Market, by Disease
-
Rest of Asia Pacific
- Rest of Asia Pacific Primary Immunodeficiency Disorders Market, by Disease
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
- Others
- Rest of Asia Pacific Primary Immunodeficiency Disorders Market, by Treatment
- Immunoglobulin Replacement Therapy
- Antibiotic Therapy
- Stem Cell/Bone Marrow Transplantation
- Gene Therapy
- Others
- Rest of Asia Pacific Primary Immunodeficiency Disorders Market, by Disease
-
Asia Pacific Primary Immunodeficiency Disorders Market, by Disease
- Latin America
-
Latin America Primary Immunodeficiency Disorders Market, by Disease
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
- Others
-
Latin America Primary Immunodeficiency Disorders Market, by Treatment
- Immunoglobulin Replacement Therapy
- Antibiotic Therapy
- Stem Cell/Bone Marrow Transplantation
- Gene Therapy
- Others
- Brazil
- Brazil Primary Immunodeficiency Disorders Market, by Disease
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
- Others
- Brazil Primary Immunodeficiency Disorders Market, by Treatment
- Immunoglobulin Replacement Therapy
- Antibiotic Therapy
- Stem Cell/Bone Marrow Transplantation
- Gene Therapy
- Others
- Brazil Primary Immunodeficiency Disorders Market, by Disease
- Argentina
- Argentina Primary Immunodeficiency Disorders Market, by Disease
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
- Others
- Argentina Primary Immunodeficiency Disorders Market, by Treatment
- Immunoglobulin Replacement Therapy
- Antibiotic Therapy
- Stem Cell/Bone Marrow Transplantation
- Gene Therapy
- Others
- Argentina Primary Immunodeficiency Disorders Market, by Disease
-
Rest of Latin America
- Rest of Latin America Primary Immunodeficiency Disorders Market, by Disease
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
- Others
- Rest of Latin America Primary Immunodeficiency Disorders Market, by Treatment
- Immunoglobulin Replacement Therapy
- Antibiotic Therapy
- Stem Cell/Bone Marrow Transplantation
- Gene Therapy
- Others
- Rest of Latin America Primary Immunodeficiency Disorders Market, by Disease
-
Latin America Primary Immunodeficiency Disorders Market, by Disease
- Middle East & Africa
-
Middle East & Africa Primary Immunodeficiency Disorders Market, by Disease
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
- Others
-
Middle East & Africa Primary Immunodeficiency Disorders Market, by Treatment
- Immunoglobulin Replacement Therapy
- Antibiotic Therapy
- Stem Cell/Bone Marrow Transplantation
- Gene Therapy
- Others
- GCC Countries
- GCC Countries Primary Immunodeficiency Disorders Market, by Disease
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
- Others
- GCC Countries Primary Immunodeficiency Disorders Market, by Treatment
- Immunoglobulin Replacement Therapy
- Antibiotic Therapy
- Stem Cell/Bone Marrow Transplantation
- Gene Therapy
- Others
- GCC Countries Primary Immunodeficiency Disorders Market, by Disease
- South Africa
- South Africa Primary Immunodeficiency Disorders Market, by Disease
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
- Others
- South Africa Primary Immunodeficiency Disorders Market, by Treatment
- Immunoglobulin Replacement Therapy
- Antibiotic Therapy
- Stem Cell/Bone Marrow Transplantation
- Gene Therapy
- Others
- South Africa Primary Immunodeficiency Disorders Market, by Disease
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Primary Immunodeficiency Disorders Market, by Disease
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
- Others
- Rest of Middle East & Africa Primary Immunodeficiency Disorders Market, by Treatment
- Immunoglobulin Replacement Therapy
- Antibiotic Therapy
- Stem Cell/Bone Marrow Transplantation
- Gene Therapy
- Others
- Rest of Middle East & Africa Primary Immunodeficiency Disorders Market, by Disease
-
Middle East & Africa Primary Immunodeficiency Disorders Market, by Disease
- North America
FAQ
Frequently Asked Question
What is the global demand for Primary Immunodeficiency Disorders in terms of revenue?
-
The global Primary Immunodeficiency Disorders valued at USD 7.08 Billion in 2023 and is expected to reach USD 12.17 Billion in 2032 growing at a CAGR of 6.2%.
Which are the prominent players in the market?
-
The prominent players in the market are Abbott Laboratories, Baxter International, CSL Behring, Takeda Pharmaceutical, Bio Products Laboratory, LFB, ADMA Biologics, Astellas Pharma, Octapharma, Biotest, Grifols, Kedrion Biopharma.
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 6.2% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Primary Immunodeficiency Disorders include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Primary Immunodeficiency Disorders in 2023.
